AU Patent

AU2019309520B2 — Spinosyn formulations for treatment of demodex-induced ocular and facial conditions

Assigned to Aperta Biosciences LLC · Expires 2025-04-03 · 1y expired

What this patent protects

The present invention concerns materials and methods for treating an ocular

USPTO Abstract

The present invention concerns materials and methods for treating an ocular

Drugs covered by this patent

Xdemvy (LOTILANER) · Tarsus

Patent Metadata

Patent number: AU2019309520B2
Jurisdiction: AU
Classification: —
Expires: 2025-04-03
Drug substance claim: No
Drug product claim: No
Assignee: Aperta Biosciences LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.